Phase I clinical trial of the intraperitoneal (IP) administration of a novel nanoparticle formulation of paclitaxel (NTX).
Stephen K. Williamson
Research Funding - CritiTech
Jo Wick
No relevant relationships to disclose
Julia A. Chapman
No relevant relationships to disclose
Gary Johnson
No relevant relationships to disclose
Greg Reed
No relevant relationships to disclose
Thomas K. Schulz
No relevant relationships to disclose
Holly Smith
No relevant relationships to disclose
Scott Weir
No relevant relationships to disclose
Charles J Decedue
Employment or Leadership Position - CritiTech
Stock Ownership - CritiTech
Jahna Howell
Employment or Leadership Position - CritiTech
Stock Ownership - CritiTech
Katherine Roby
No relevant relationships to disclose